NDC 25021-182
Cefuroxime sodium
Cefuroxime Sodium
Cefuroxime sodium is a Intramuscular; Intravenous Injection, Powder, For Solution in the Human Prescription Drug category. It is labeled and distributed by Sagent Pharmaceuticals. The primary component is Cefuroxime Sodium.
| Product ID | 25021-182_3013653c-01f3-4ec7-a7fa-3e7b49adc4f0 |
| NDC | 25021-182 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Cefuroxime sodium |
| Generic Name | Cefuroxime Sodium |
| Dosage Form | Injection, Powder, For Solution |
| Route of Administration | INTRAMUSCULAR; INTRAVENOUS |
| Marketing Start Date | 2016-09-01 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA064125 |
| Labeler Name | Sagent Pharmaceuticals |
| Substance Name | CEFUROXIME SODIUM |
| Active Ingredient Strength | 750 mg/1 |
| Pharm Classes | Cephalosporin Antibacterial [EPC],Cephalosporins [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |